论文部分内容阅读
本文报道了猴脾转移因子(TFⅢ)与人脾转移因子(TFⅠ)治疗小儿复发性呼吸道感染的效果比较,结果表明,TFⅡ的临床疗效与TFⅠ相同,最后讨论了TFⅢ的应用前景。
In this paper, we compared the efficacy of TFIII and TFI in the treatment of children with recurrent respiratory tract infection. The results showed that the clinical efficacy of TFII was the same as that of TFI. Finally, the application prospect of TFIII was discussed.